Skip to main content
Log in

Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Levels of 5-hydroxyindoleacetic acid and homovanillic acid were measured in cerebrospinal fluid from 33 depressed women with no clinical response to amitriptyline, before and after combination treatment with triiodothyronine. Although the latter showed significant clinical improvement, changes in CSF amine metabolites did not differ significantly from a control group of 16 therapy-resistant depressed women receiving higher doses of amitriptyline. Possible explanations for the mechanism of action of triiodothyronine are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

5-HIAA:

5-hydroxyindoleacetic acid

HVA:

homovanillic acid

CSF:

cerebrospinal fluid

T3 :

triiodothyronine

References

  1. Abdullah, Y. H., Hamadah, K.: 3′5′-cyclic adenosine monophosphate in depression and mania. Lancet1970 I, 378–381

    Google Scholar 

  2. Akiskal, H. S., McKinney, W. T.: Overview of recent research in depression. Arch. gen. Psychiat.32, 285–305 (1975)

    Google Scholar 

  3. Ashcroft, G., Crawford, T., Eccleston, E., Sharman, D. F., McDougall, E. J., Stanton, J. B., Binns, K.: 5-hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological diseases. Lancet1966 II, 1049–1052

    Google Scholar 

  4. Banki, C. M.: Triiodothyronine in the treatment of depression. Orv. Hetil.116, 2543–2547 (1975)

    Google Scholar 

  5. Banki, C. M.: Cerebrospinal fluid 5-hydroxyindoleacetic acid in mania and depression. Ideggyóg. Szle29, 467–479 (1976)

    Google Scholar 

  6. Banki, C. M.: Cerebrospinal fluid homovanillic acid concentrations in manic and depressed patients. Ideggyóg. Szle (in press)

  7. Breulet, M., Bourdouxhe, S., Parent, M., Legros, J. J., Bobon, J.: Clinical and neuroendocrinological study of the TRH in melancholia. Acta psychiat. Belg.74, 254–277 (1974)

    Google Scholar 

  8. Brodie, B. B., Davis, J. I., Heynie, S.: Interrelationships of catecholamines with other endocrine systems. Pharmacol. Rev.18, 273–281 (1966)

    Google Scholar 

  9. Cavalca, G. G., Covezzi, E., Boncinelli, A.: Clinical experiences with the combination of thyroid extract and tricyclics in the treatment of depressed patients. Riv. sper. Freniat.98, 271–300 (1974)

    Google Scholar 

  10. Coppen, A., Prange, A. J., Whybrow, P. C., Noguera, R.: Abnormalities of indoleamines in affective disorders. Arch. gen. Psychiat.26, 474–478 (1972)

    Google Scholar 

  11. Dencker, S., Malm, U., Roos, B. E.: Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania. J. Neurochem.13, 1545–1548 (1966)

    Google Scholar 

  12. Earle, B. V.: Thyroid hormone and tricyclic antidepressants in resistant depressions. Amer. J. Psychiat.126, 1667–1669 (1970)

    Google Scholar 

  13. Fuxe, K., Ungerstedt, U.: Histochemical studies on the effect of (+)-amphetamine, drugs of the imipramine group and tryptamine on central catecholamine and 5-hydroxytryptamine neurons after intraventricular injection of catecholamines and 5-HT. Europ. J. Pharmacol.4, 135–144 (1968)

    Google Scholar 

  14. Gerbode, F. A., Bowers, M. B.: Measurement of acid monoamine metabolites in human and animal cerebrospinal fluid. J. Neurochem.15, 1053–1055 (1968)

    Google Scholar 

  15. Glowinski, J., Axelrod, J.: Inhibition of uptake of tritiated noradrenaline in the intact brain by imipramine and structurally related compounds. Nature204, 1318–1319 (1964)

    Google Scholar 

  16. Hamilton, M.: A rating scale for depression. J. Neurol. Neurosurg. Psychiat.23, 56–62 (1960)

    Google Scholar 

  17. Korf, J., Valkenburgh-Sikkema, T.: Fluorimetric determination of 5-hydroxyindoleacetic acid in human urine and cerebrospinal fluid. Clin. chim. Acta26, 301–306 (1969)

    Google Scholar 

  18. Mathematik und Statistik. Basel: Documenta Geigy 1975

  19. Mendels, J., Frazer, A., Fitzgerald, R. G., Ramsey, T. A., Stokes, J. W.: Biogenic amine metabolites in cerebrospinal fluid of depressed and manic patients. Science175, 1380–1382 (1972)

    Google Scholar 

  20. Ogura, C., Okuma, T., Uchida, Y., Kato, N.: Combined triiodothyroninetricyclic antidepressant treatment in depressive states. Folia psychiat. neurol. jap.28, 179–186 (1974)

    Google Scholar 

  21. Papeschi, R., McClure, D. J.: Homovanillic acid and 5-hydroxyindoleacetic acid in cerebrospinal fluid of depressed patients. Arch. gen. Psychiat.25, 354–358 (1971)

    Google Scholar 

  22. Paul, M. I., Ditzion, B. R., Pauk, G. L., Janowsky, D. S.: Urinary adenosine-3′5′-monophosphate excretion in affective disorders. Amer. J. Psychiat.126, 1493–1497 (1970)

    Google Scholar 

  23. Prange, A. J., Wilson, I. C., Rabon, A. M., Lipton, M. A.: Enhancement of imipramine by triiodothyronine in nonselected depressed patients. Excerpta med. Int. Congress Series180, 532–535 (1968)

    Google Scholar 

  24. Prange, A. J., Wilson, I. C., Rabon, A. M., Lipton, M. A.: Enhancement of imipramine antidepressant activity by thyroid hormone. Amer. J. Psychiat.126, 457–469 (1969)

    Google Scholar 

  25. Prange, A. J., Wilson, I. C., Knox, A., McClane, T. K., Lipton, M. A.: Enhancement of imipramine by thyroid stimulating hormone: clinical and theoretical implications. Amer. J. Psychiat.127, 191–199 (1970)

    Google Scholar 

  26. Ramsden, E. N.: Cyclic AMP in depression and mania. Lancet1970 II, 108–110

    Google Scholar 

  27. Sabelli, H. C., Mosnaim, A. D., Vazquez, A. J.: Phenylethylamine, possible role in depression and antidepressive drug action. In: Neurohumoral coding of brain function, (eds. R. D. Myers, R. R. Drucker-Colin) pp. 331–357. New York: Plenum Publ. Co. 1975

    Google Scholar 

  28. Schildkraut, J. J., Winokur, A., Applegate, C. W.: Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine. Science168, 867–869 (1970)

    Google Scholar 

  29. Sinanan, K., Keatinge, A. M., Beckett, P. G., Clayton-Love, W.: Urinary cyclic AMP in endogenous and neurotic depression. Brit. J. Psychiat.126, 49–55 (1975)

    Google Scholar 

  30. Sjöström, R., Roos, B. E.: 5-hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid of manic-depressive psychoses. Europ. J. clin. Pharmacol.4, 170–176 (1972)

    Google Scholar 

  31. Van Praag, H. M., Korf, J.: Retarded depression and dopamine metabolism. Psychopharmacologia (Berl.)19, 199–203 (1971)

    Google Scholar 

  32. Van Praag, H. M, Korf, J., Schut, J.: Cerebral monoamines and depression; investigation with the probenecid technique. Arch. gen. Psychiat.28, 827–832 (1973)

    Google Scholar 

  33. Wilson, I. C., Prange, A. J., McClane, T. K., Rabon, A. M., Lipton, M. A.: Thyroid hormone enhancement of imipramine in non-retarded depressions. New Engl. J. Med.282, 1063–1067 (1970)

    Google Scholar 

  34. Wheatley, D.: Potentiation of amitriptyline by thyroid hormone. Arch. gen. Psychiat.26, 229–233 (1972)

    Google Scholar 

  35. Whybrow, P. C., Prange, A. J., Treadway, D. R.: Mental changes accompanying thyroid gland dysfunction. Arch. gen. Psychiat.20, 48–63 (1969)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Banki, C.M. Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women. Eur J Clin Pharmacol 11, 311–315 (1977). https://doi.org/10.1007/BF00607682

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00607682

Key words

Navigation